← Insider buys
ADAP

Adaptimmune Therapeutics Plc · HEALTHCARE

CEO Adrian Rawcliffe sold $28K of Adaptimmune Therapeutics Plc

Sold$27,594
$0.70Price
39,384Shares
−47%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Tue, Jan 16. Filed Wed, Jan 17. Not investment advice.